Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...
Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.
The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...
The LDS Church's stock investments at Ensign Peak Advisors have climbed to a new high in value at $60.9 billion. That's ...
A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration ...
Stocktwits on MSN
BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company
The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...
New data the Agriculture Department released Friday created serious doubts about whether China will really buy millions of ...
In a year when the big private equity firms in the S&P 500 have faltered, one of the FTSE 100’s top performers is going from strength to strength. The post This FTSE 100 star is quietly beating the US ...
InvestorsHub on MSN
BioNTech Rejects Talk of Pfizer Stake Sale, Says Partnership Is Intact
BioNTech (NASDAQ:BNTX) pushed back on speculation Thursday that Pfizer (NYSE:PFE) may be preparing to unload its stake in the ...
In his new book, 'Fair Doses,' epidemiologist Seth Berkley discusses what went right -- and wrong -- with COVID vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback